Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block

NCT02064530 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-09-14

No results posted yet for this study

Summary

the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added to bupivacaine on TAP block in patients undergoing lower abdominal surgery.

Conditions

Interventions

DRUG

Bupivacaine

21 ml 0.5 %bupivacaine is applied interfasially

DRUG

Dexmedetomidine

1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied interfasially

DRUG

serum physiologic

21 ml serum physiologic is applied interfasially

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Recep Aksu, assoc. prof. · Erciyes universty medicine faculty

  • Gülçin Patmano, resident · Erciyes universty medicine faculty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064530 on ClinicalTrials.gov